UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 719

Sortiert nach

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

Blood, 2019-01, Vol.133 (1), p.7-17

2019

Volltextzugriff (PDF)

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

Nature communications, 2018-01, Vol.9 (1), p.42-13, Article 42

2018

Volltextzugriff (PDF)

Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening

Blood cancer discovery, 2023-11, Vol.4 (6), p.437

Becker, Pamela S

2023

Volltextzugriff (PDF)

Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia

Current gene therapy, 2016-10, Vol.16 (5), p.338

2016

Volltextzugriff (PDF)

Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study

American journal of hematology, 2021-02, Vol.96 (2), p.208-217

2021

Volltextzugriff (PDF)

Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes

Blood, 2019-07, Vol.134 (2), p.186-198

2019

Volltextzugriff (PDF)

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia

Blood, 2022-02, Vol.139 (8), p.1135-1146

2022

Volltextzugriff (PDF)

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia

Journal of clinical oncology, 2015-04, Vol.33 (11), p.1258-1264

2015

Volltextzugriff (PDF)

Unsupervised discovery of dynamic cell phenotypic states from transmitted light movies

PLoS computational biology, 2021-12, Vol.17 (12), p.e1009626-e1009626

2021

Volltextzugriff (PDF)

Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm

Journal of clinical oncology, 2020-12, Vol.38 (35), p.4163-4174

2020

Volltextzugriff (PDF)

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Clinical cancer research, 2020-12, Vol.26 (23), p.6132-6140

2020

Volltextzugriff (PDF)

Dependence of Acute Myeloid Leukemia on Adhesion within the Bone Marrow Microenvironment

TheScientificWorld, 2012-01, Vol.2012, p.856467-4

2012

Volltextzugriff (PDF)

A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma

Clinical cancer research, 2020-01, Vol.26 (2), p.344-353

2020

Volltextzugriff (PDF)

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long‐term safety and efficacy

British journal of haematology, 2017-09, Vol.178 (6), p.906-913

2017

Volltextzugriff (PDF)

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms

Leukemia, 2023-09, Vol.37 (9), p.1912-1914

2023

Volltextzugriff (PDF)

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

Journal of clinical oncology, 2010-01, Vol.28 (3), p.437-444

2010

Volltextzugriff (PDF)

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma

British journal of haematology, 2012-10, Vol.159 (1), p.58-66

2012

Volltextzugriff (PDF)

CD19‐directed immunotherapy use in KMT2A‐rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch

American journal of hematology, 2022-12, Vol.97 (12), p.E439-E443

2022

Volltextzugriff (PDF)

Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)

Orphanet journal of rare diseases, 2022-04, Vol.17 (1), p.145-145, Article 145

2022

Volltextzugriff (PDF)

Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function

Cell stem cell, 2022-04, Vol.29 (4), p.577-592.e8

2022

Volltextzugriff (PDF)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

Haematologica (Roma), 2019-02, Vol.104 (2), p.380

2019

Volltextzugriff (PDF)

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia

Leukemia & lymphoma, 2021-04, Vol.62 (5), p.1226-1233

2021

Volltextzugriff (PDF)

Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality

JAMA oncology, 2017-12, Vol.3 (12), p.1675

2017

Volltextzugriff (PDF)

Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney

Leukemia, 2020-10, Vol.34 (10), p.2776-2779

2020

Volltextzugriff (PDF)

1 – 25 von 719

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(613)
Mit Volltextzugriff
(632)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(356)
Life Sciences & Biomedicine
(316)
Humans
(285)
Female
(169)
Male
(163)
Middle Aged
(104)
Adult
(92)
Hematology
(91)
Aged
(86)
Biological And Medical Sciences
(79)
Medical Sciences
(73)
Oncology
(64)
Animals
(50)
Adolescent
(49)
Treatment Outcome
(45)
Aged, 80 And Over
(41)
Child
(37)
Risk Factors
(34)
Leukemia, Myeloid, Acute - Drug Therapy
(33)
Mice
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(147)
Mechanical Engineering
(32)
Journal Of Clinical Oncology
(20)
British Journal Of Haematology
(16)
Stroke
(14)
Transplantation And Cellular Therapy
(13)
Cancer Research
(12)
Leukemia & Lymphoma
(11)
Biology Of Blood And Marrow Transplantation
(10)
Revista Chilena De Infectología
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening

Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia

Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study

Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia

Unsupervised discovery of dynamic cell phenotypic states from transmitted light movies

Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Dependence of Acute Myeloid Leukemia on Adhesion within the Bone Marrow Microenvironment

A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long‐term safety and efficacy

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma

CD19‐directed immunotherapy use in KMT2A‐rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch

Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)

Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia

Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney

Suchergebnisse filtern